CTMX - Cytomx Therapeutics, Inc.

CTMX sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	McCarthy Sean A.	1.08M	$6.93M	-
VP	Belvin Marcia	300.8K	$1.93M	-
CFO	Ogden Christopher	295.3K	$900.7K	-
Other	Chu Yu-Waye	189.4K	$1.22M	-
Other	Carvajal Alejandra	100.0K	-	-

Buys and sells only

10 filings · page 3

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 19, 2024	Rowland Lloyd A50	General Counsel	Sell	5,268	$2.09	$10,986.41	-4.3%	-37.2%	-69.3%
Mar 19, 2024	McCarthy Sean A.68	CEO	Sell	20,223	$2.09	$42,175.07	-3.7%	-37.2%	-69.3%
Mar 19, 2024	Ogden Christopher53	SVP, Finance and Accounting	Sell	2,971	$2.09	$6,196.02	-3.4%	-37.2%	-69.3%
Mar 19, 2024	Belvin Marcia52	SVP, Chief Scientific Officer	Sell	12,795	$2.09	$26,683.97	-7.1%	-37.2%	-69.3%
Mar 19, 2024	Landau Jeffrey B55	Chief Business Officer	Sell	6,562	$2.09	$13,685.05	-5.6%	-37.2%	-69.3%
Dec 20, 2023	McCarthy Sean A.68	CEO	Sell	13,551	$1.38	$18,709.87	-2.9%	+62.7%	-17.9%
Dec 20, 2023	Belvin Marcia52	SVP, Chief Scientific Officer	Sell	4,077	$1.38	$5,628.30	-2.6%	+62.7%	-17.9%
Dec 20, 2023	Landau Jeffrey B55	Chief Business Officer	Sell	4,077	$1.38	$5,628.30	-4.5%	+62.7%	-17.9%
Dec 20, 2023	Rowland Lloyd A50	General Counsel	Sell	4,077	$1.38	$5,629.11	-4.0%	+62.7%	-17.9%
Dec 20, 2023	Ogden Christopher53	SVP, Finance and Accounting	Sell	1,990	$1.38	$2,747.39	-3.9%	+62.7%	-17.9%